You just read:

Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease

News provided by

Shire plc

Dec 05, 2013, 05:30 ET